AKR1B10 positivity was more prominent in advanced NAFLD, and was observed in ballooned hepatocytes and hepatocytes neighbouring necro-inflammatory foci and periportal/periseptal areas (Fig. 2d). Here, AKR1B10 is linked to metabolic dysfunction-associated steatotic liver disease.